GlassScriptPhysician profile
Olimpia A Radu
NPI 1447247788
$1,909.02
in general payments reported to CMS, 2019-2025
23 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $108 · 2022: $65.25 · 2023: $53.13 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $420.52 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.03 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $171.79 | 2019-2023 | Uptravi |
| Grifols USA, LLC | $149.31 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $145.61 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $129.05 | 2019 | |
| Mallinckrodt Enterprises LLC | $110.71 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $87.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $81.03 | 2019 | |
| Jazz Pharmaceuticals INC. | $65.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $53.41 | 2019 | |
| Insmed, INC. | $34.81 | 2019 | |
| Alexion Pharmaceuticals, INC. | $33.68 | 2019 | |
| Merck Sharp & Dohme LLC | $29.16 | 2019 | |
| Circassia INC. | $24.18 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $23.35 | 2019 | |
| Vapotherm INC | $21.63 | 2022 | |
| Electromed, INC. | $19.42 | 2019 | |
| Genzyme Corporation | $18.57 | 2019 | |
| Mylan Specialty L.P. | $17.62 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.61 | 2020 | |
| Pfizer INC. | $15.00 | 2019 | |
| Genentech USA, INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olimpia Radu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.